BioCentury
ARTICLE | Politics, Policy & Law

White House backs limited Medicare drug reform legislation

March 10, 2020 7:25 PM UTC
Updated on Mar 10, 2020 at 8:19 PM UTC

The White House is backing a limited set of Medicare drug pricing reforms and hopes to have them included in legislation that is slated for enactment in May.

Joe Grogan, director of the White House Domestic Policy Council, outlined the White House position in a commentary published Tuesday in The Wall Street Journal. ...